B

Bernard Moss

National Institute of Allergy and Infectious Diseases

ORCID: 0000-0002-2154-8564

977 papers and 81.9k citations.

PubIndex Score98Top 2%How it's scored

🌟#1 Current Senior Leader in Bacteriophages and microbial interactions 🌟#1 Current Senior Leader in Poxvirus research and outbreaks 🌟#2 Current Senior Leader in Herpesvirus Infections and Treatments 🌟#2 Current Senior Leader in Virus-based gene therapy research 🌟#8 Current Senior Leader in Bacillus and Francisella bacterial research

977Publications

81.9kTotal Citations

#1in Bacteriophages and microbial interactions

First publication: 1948First senior author: 1950

Top publicationsby citations

Poxvirus DNA Replication

Bernard Moss|Cold Spring Harbor Perspectives in Biology|2013

Cited by 377

Poxvirus Cell Entry: How Many Proteins Does it Take?

Bernard Moss|Viruses|2012

Cited by 262

Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles

Paul Goepfert, Harriet L. Robinson, Marnie Elizaga et al.|The Journal of Infectious Diseases|2011

Cited by 177

Specificity and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles

Paul Goepfert, Harriet L. Robinson, Marnie Elizaga et al.|The Journal of Infectious Diseases|2014

Cited by 84

Zinc-finger antiviral protein (ZAP) is a restriction factor for replication of modified vaccinia virus Ankara (MVA) in human cells

Chen Peng, Bernard Moss|PLoS Pathogens|2020

Cited by 49

Indexing the rest of 977 publications…